Ayta, Bb Girl .

HRN: 27-66-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/18/2025
08/25/2025
IV
42mg
Q12
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines